Format

Send to

Choose Destination
Methods Mol Biol. 2020;2058:127-132. doi: 10.1007/978-1-4939-9794-7_8.

A Functional Assay to Determine the Capacity of Oncolytic Viruses to Induce Immunogenic Tumor Cell Death.

Author information

1
CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.
2
Immunology Graft Oncology, Labex IGO, Nantes, France.
3
CNRS 3569, Institut Pasteur, Paris, France.
4
CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France. jean-francois.fonteneau@inserm.fr.
5
Immunology Graft Oncology, Labex IGO, Nantes, France. jean-francois.fonteneau@inserm.fr.

Abstract

Oncolytic immunotherapy efficacy relies partially on the induction of immunogenic tumor cell death following infection with oncolytic viruses (OV) to induce an antitumor immune response. Here, we describe a method to determine if an OV is able to induce such an immunogenic tumor cell death. This method consists in testing whether tumor cells lysed by an OV are able to induce the maturation of human monocyte-derived immature dendritic cells (Mo-iDC).

KEYWORDS:

Antigen-presenting cells; Dendritic cells; Flow cytometry; Immunogenic cell death; Oncolytic viruses

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center